{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:21:47Z","timestamp":1784607707002,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["1I01BX000357"],"award-info":[{"award-number":["1I01BX000357"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["IK6BX005646"],"award-info":[{"award-number":["IK6BX005646"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY030774"],"award-info":[{"award-number":["R01EY030774"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["U01EY031650"],"award-info":[{"award-number":["U01EY031650"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtos.2024.01.001","type":"journal-article","created":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T04:28:28Z","timestamp":1704515308000},"page":"13-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1857-4200","authenticated-orcid":false,"given":"Rajiv R.","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneel","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajnish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant R.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Landreneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant R.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam S.","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Hesemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2\u20133","key":"10.1016\/j.jtos.2024.01.001_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.brainresbull.2009.05.019","article-title":"Corneal transparency: genesis, maintenance and dysfunction","volume":"81","author":"Qazi","year":"2010","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jtos.2024.01.001_bib2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/01.ico.0000178743.06340.2c","article-title":"How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes","volume":"4","author":"Fini","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2024.01.001_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.exer.2010.06.021","article-title":"The molecular basis of corneal transparency","volume":"91","author":"Hassell","year":"2010","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2024.01.001_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1350-9462(01)00008-8","article-title":"The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells","volume":"20","author":"Wilson","year":"2001","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1001\/archopht.122.4.477","article-title":"Causes and prevalence of visual impairment among adults in the United States","volume":"122","author":"Congdon","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jtos.2024.01.001_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib7","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jtos.2018.06.004","article-title":"Current and emerging therapies for corneal neovascularization","volume":"16","author":"Roshandel","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.01.001_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis. (Lond)"},{"issue":"7","key":"10.1016\/j.jtos.2024.01.001_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.11.7.9","article-title":"Topical losartan and corticosteroid additively inhibit corneal stromal myofibroblast generation and scarring fibrosis after alkali burn injury","volume":"11","author":"Sampaio","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"9","key":"10.1016\/j.jtos.2024.01.001_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/tvst.12.9.20","article-title":"Topical losartan decreases myofibroblast generation but not corneal opacity after surface blast-simulating irregular PTK in rabbits","volume":"12","author":"Sampaio","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","article-title":"Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study","volume":"127","author":"Dastjerdi","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib13","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.01.001_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J Contr Release"},{"issue":"7","key":"10.1016\/j.jtos.2024.01.001_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/pharmaceutics11070321","article-title":"Penetration enhancers in ocular drug delivery","volume":"11","author":"Moiseev","year":"2019","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40123-021-00365-y","article-title":"The emerging role of topical ocular drugs to target the posterior eye","volume":"10","author":"Wang","year":"2021","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2024.01.001_bib17","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","volume":"13","author":"Walsh","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2024.01.001_bib18","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1016\/j.ymthe.2022.06.018","article-title":"Corneal fibrosis abrogation by a localized AAV-mediated inhibitor of differentiation 3 (Id3) gene therapy in rabbit eyes in vivo","volume":"30","author":"Gupta","year":"2022","journal-title":"Mol Ther"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018771","article-title":"Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea","volume":"6","author":"Mohan","year":"2011","journal-title":"PLoS One"},{"issue":"2\u20133","key":"10.1016\/j.jtos.2024.01.001_bib20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.brainresbull.2009.07.005","article-title":"Transduction efficiency of AAV 2\/6, 2\/8 and 2\/9 vectors for delivering genes in human corneal fibroblasts","volume":"81","author":"Sharma","year":"2010","journal-title":"Brain Res Bull"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.exer.2010.06.020","article-title":"AAV serotype influences gene transfer in corneal stroma in vivo","volume":"91","author":"Sharma","year":"2010","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.jtos.2024.01.001_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1463-5224.2010.00813.x","article-title":"Gene delivery in the equine cornea: a novel therapeutic strategy","volume":"13","author":"Buss","year":"2010","journal-title":"Vet Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2024.01.001_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1463-5224.2011.00980.x","article-title":"Canine corneal fibroblast and myofibroblast transduction with AAV5","volume":"15","author":"Bosiack","year":"2012","journal-title":"Vet Ophthalmol"},{"key":"10.1016\/j.jtos.2024.01.001_bib24","first-page":"2494","article-title":"Vector delivery technique affects gene transfer in the cornea in vivo","volume":"16","author":"Mohan","year":"2010","journal-title":"Mol Vis"},{"issue":"7","key":"10.1016\/j.jtos.2024.01.001_bib25","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1167\/iovs.11-7357","article-title":"Significant inhibition of corneal scarring in vivo with tissue-selective, targeted AAV5 decorin gene therapy","volume":"52","author":"Mohan","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2024.01.001_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026432","article-title":"Targeted decorin gene therapy delivered with adeno-associated virus effectively retards corneal neovascularization in vivo","volume":"6","author":"Mohan","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/156652411794859241","article-title":"Decorin biology, expression, function, and therapy in the cornea","volume":"11","author":"Mohan","year":"2011","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.jtos.2024.01.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108361","article-title":"Novel insights into gene therapy in the cornea","volume":"202","author":"Mohan","year":"2021","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2024.01.001_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.exer.2019.01.001","article-title":"Decorin antagonizes corneal fibroblast migration via caveolae-mediated endocytosis of epidermal growth factor receptor","volume":"180","author":"Mohan","year":"2019","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018771","article-title":"Efficacious and safe tissue-selective controlled gene therapy approaches for the cornea","volume":"6","author":"Mohan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2024.01.001_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101090","article-title":"Corneal stromal repair and regeneration","volume":"91","author":"Mohan","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/vop.12060","article-title":"Decorin-PEI nanoconstruct attenuates equine corneal fibroblast differentiation","volume":"17","author":"Donnelly","year":"2014","journal-title":"Vet Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/vop.12485","article-title":"Altering equine corneal fibroblast differentiation through Smad gene transfer","volume":"21","author":"Marlo","year":"2018","journal-title":"Vet Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","article-title":"Horizons in therapy for corneal angiogenesis","volume":"118","author":"Maddula","year":"2011","journal-title":"Ophthalmology"},{"issue":"2\u20133","key":"10.1016\/j.jtos.2024.01.001_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mvr.2007.03.004","article-title":"Roles for VEGF in the adult","volume":"74","author":"Maharaj","year":"2007","journal-title":"Microvasc Res"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2010.05.013","article-title":"Decorin transfection suppresses profibrogenic genes and myofibroblast formation in human corneal fibroblasts","volume":"91","author":"Mohan","year":"2010","journal-title":"Exp Eye Res"},{"issue":"5425","key":"10.1016\/j.jtos.2024.01.001_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.285.5425.245","article-title":"Pigment epithelium-derived factor: a potent inhibitor of angiogenesis","volume":"285","author":"Dawson","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib39","first-page":"821","article-title":"Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth","volume":"43","author":"Duh","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.jtos.2024.01.001_bib40","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrn1176","article-title":"PEDF: a multifaceted neurotrophic factor","volume":"4","author":"Tombran-Tink","year":"2003","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"10.1016\/j.jtos.2024.01.001_bib41","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/138945008786786154","article-title":"Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications","volume":"9","author":"Yamagishi","year":"2008","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib42","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/156652410791065336","article-title":"PEDF in angiogenic eye diseases","volume":"10","author":"Tombran-Tink","year":"2010","journal-title":"Curr Mol Med"},{"issue":"5","key":"10.1016\/j.jtos.2024.01.001_bib43","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1073\/pnas.031252398","article-title":"Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor","volume":"98","author":"Stellmach","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.jtos.2024.01.001_bib44","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2337\/diabetes.50.12.2641","article-title":"Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease","volume":"50","author":"Spranger","year":"2001","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib45","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"Campochiaro","year":"2006","journal-title":"Hum Gene Ther"},{"issue":"16","key":"10.1016\/j.jtos.2024.01.001_bib46","first-page":"2029","article-title":"Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD)","volume":"12","author":"Rasmussen","year":"2001","journal-title":"Hum Gene Ther"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2017.09.005","article-title":"Treatment of acute ocular chemical burns","volume":"63","author":"Sharma","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1167\/iovs.17-23308","article-title":"Novel combination BMP7 and HGF gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo","volume":"59","author":"Gupta","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.jtos.2024.01.001_bib49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1089\/jop.2017.0108","article-title":"The SPOTS System: an ocular scoring system optimized for use in modern preclinical drug development and toxicology","volume":"33","author":"Eaton","year":"2017","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"10","key":"10.1016\/j.jtos.2024.01.001_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.10.10.5","article-title":"Six-month in vivo safety profiling of topical ocular AAV5-Decorin gene transfer","volume":"10","author":"Mohan","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.jtos.2024.01.001_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172928","article-title":"Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo","volume":"12","author":"Gupta","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jtos.2024.01.001_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53123-3","article-title":"Identification of novel predictive factors for post-surgical corneal haze","volume":"9","author":"Kumar","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtos.2024.01.001_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.exer.2015.09.010","article-title":"Development of a novel in vivo corneal fibrosis model in the dog","volume":"143","author":"Gronkiewicz","year":"2016","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2024.01.001_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.108933","article-title":"Decorin regulates collagen fibrillogenesis during corneal wound healing in mouse in vivo","volume":"216","author":"Gupta","year":"2022","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib55","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nm0402-349","article-title":"Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor","volume":"8","author":"Volpert","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jtos.2024.01.001_bib56","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1440-1711.1999.00837.x","article-title":"Cell death induced by the Fas\/Fas ligand pathway and its role in pathology","volume":"77","author":"Waring","year":"1999","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jtos.2024.01.001_bib57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jtos.2020.10.006","article-title":"Corneal stromal wound healing: major regulators and therapeutic targets","volume":"19","author":"Kamil","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.01.001_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.preteyeres.2015.07.002","article-title":"Progress in corneal wound healing","volume":"49","author":"Ljubimov","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jtos.2024.01.001_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109443","article-title":"Standardization of corneal alkali burn methodology in rabbits","volume":"230","author":"Villabona-Martinez","year":"2023","journal-title":"Exp Eye Res"},{"issue":"9","key":"10.1016\/j.jtos.2024.01.001_bib60","article-title":"Amniotic membrane transplantation for acute ocular burns","volume":"9","author":"Clare","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1542-0124(12)70128-3","article-title":"Growth factor, cytokine and protease interactions during corneal wound healing","volume":"1","author":"Lim","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2024.01.001_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109644","article-title":"Differential gene expression and protein-protein interaction network profiling of sulfur mustard-exposed rabbit corneas employing RNA-seq data and bioinformatics tools","volume":"235","author":"Kumar","year":"2023","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.jtos.2024.01.001_bib63","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.drudis.2019.03.005","article-title":"Drug delivery systems and novel formulations to improve treatment of rare corneal disease","volume":"24","author":"Jimenez","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jtos.2024.01.001_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114868","article-title":"Trans-corneal drug delivery strategies in the treatment of ocular diseases","volume":"198","author":"Li","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jtos.2024.01.001_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jtos.2023.05.007","article-title":"Corneal gene therapy: structural and mechanistic understanding","volume":"29","author":"Kumar","year":"2023","journal-title":"Ocul Surf"},{"issue":"12","key":"10.1016\/j.jtos.2024.01.001_bib66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.9.12.6","article-title":"A novel topical ophthalmic formulation to mitigate acute mustard gas keratopathy in vivo: a pilot study","volume":"9","author":"Tripathi","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.jtos.2024.01.001_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1167\/iovs.62.4.8","article-title":"Interleukin-1 and transforming growth factor beta: commonly opposing, but sometimes supporting, master regulators of the corneal wound healing response to injury","volume":"62","author":"Wilson","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"15","key":"10.1016\/j.jtos.2024.01.001_bib68","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cells11152336","article-title":"TGF-\u0392 superfamily signaling in the eye: implications for ocular pathologies","volume":"11","author":"Hachana","year":"2022","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.jtos.2024.01.001_bib69","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.stemcr.2022.04.017","article-title":"Notch1 signaling in keratocytes maintains corneal transparency by suppressing VEGF expression","volume":"17","author":"Biswas","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"1","key":"10.1016\/j.jtos.2024.01.001_bib70","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180552","article-title":"Inhibited corneal neovascularization in rabbits following corneal alkali burn by double-target interference for VEGF and HIF-1\u03b1","volume":"39","author":"Fu","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jtos.2024.01.001_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.exer.2014.09.013","article-title":"Cellular and extracellular matrix modulation of corneal stromal opacity","volume":"129","author":"Torricelli","year":"2014","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2024.01.001_bib72","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1006\/mvre.2001.2311","article-title":"Decorin inhibits endothelial migration and tube-like structure formation: role of thrombospondin-1","volume":"62","author":"Davies Cde","year":"2001","journal-title":"Microvasc Res"},{"issue":"31","key":"10.1016\/j.jtos.2024.01.001_bib73","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1038\/sj.onc.1205595","article-title":"Decorin suppresses tumor cell-mediated angiogenesis","volume":"21","author":"Grant","year":"2002","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.jtos.2024.01.001_bib74","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1167\/iovs.08-2878","article-title":"Antipermeability function of PEDF involves blockade of the MAP kinase\/GSK\/beta-catenin signaling pathway and uPAR expression","volume":"51","author":"Yang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.jtos.2024.01.001_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00006982-200204000-00002","article-title":"Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration","volume":"22","year":"2002","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.jtos.2024.01.001_bib76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/0974-9233.172294","article-title":"Clinical trials in branch retinal vein occlusion","volume":"23","author":"Panakanti","year":"2016","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2024.01.001_bib77","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic retinopathy: pathophysiology and treatments","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.jtos.2024.01.001_bib78","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/iovs.62.7.18","article-title":"PEDF gene deletion disrupts corneal innervation and ocular surface function","volume":"62","author":"Shang","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.jtos.2024.01.001_bib79","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41419-021-03749-x","article-title":"Fas\/FasL mediates NF-\u03baBp65\/PUMA-modulated hepatocytes apoptosis via autophagy to drive liver fibrosis","volume":"12","author":"Tan","year":"2021","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.jtos.2024.01.001_bib80","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2174\/1568009620666200115161717","article-title":"Fas ligand enhances apoptosis of human lung cancer cells cotreated with RIG-I-like receptor agonist and radiation","volume":"20","author":"Sato","year":"2020","journal-title":"Curr Cancer Drug Targets"},{"issue":"12","key":"10.1016\/j.jtos.2024.01.001_bib81","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1167\/iovs.04-0598","article-title":"FAS-mediated apoptosis and its relation to intrinsic pathway activation in an experimental model of retinal detachment","volume":"45","author":"Zacks","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2024.01.001_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.11-8928","article-title":"Fas ligand-Fas signaling participates in light-induced apoptotic death in photoreceptor cells","volume":"53","author":"Chang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:23Z","timestamp":1761540563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":82,"alternative-id":["S1542012424000016"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.01.001","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}